Chimeric antigen receptor T cell

Researchers at Notre Dame University have been able to engineer a switch on immune T cell receptors, enhancing their capacity to recognize foreign proteins on cancer cells, which allows for precision targeting and killing.
Stemming from the American Society of Clinical Oncology gathering in Chicago, it will be difficult not to give into the optimism that is cancer research these days. In conjunction with significant investment from the White House and beyond, the frontier of cancer treatment has never looked so promising.